-
1
-
-
84921646968
-
Drug-induced thrombotic microangiopathy: A systematic review of published reports
-
Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015;125(4):616-618.
-
(2015)
Blood
, vol.125
, Issue.4
, pp. 616-618
-
-
Al-Nouri, Z.L.1
Reese, J.A.2
Terrell, D.R.3
Vesely, S.K.4
George, J.N.5
-
2
-
-
84908590395
-
Syndromes of thrombotic microangiopathy
-
George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371(19):1847-1848.
-
(2014)
N Engl J Med.
, vol.371
, Issue.19
, pp. 1847-1848
-
-
George, J.N.1
Nester, C.M.2
-
3
-
-
0032565185
-
Adverse drug reactions
-
Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ. 1998;316(7140):1295-1298.
-
(1998)
BMJ
, vol.316
, Issue.7140
, pp. 1295-1298
-
-
Pirmohamed, M.1
Breckenridge, A.M.2
Kitteringham, N.R.3
Park, B.K.4
-
4
-
-
84941022179
-
Type I interferon dysregulation and neurological disease
-
McGlasson S, Jury A, Jackson A, Hunt D. Type I interferon dysregulation and neurological disease. Nat Rev Neurol. 2015;11(9):515-523.
-
(2015)
Nat Rev Neurol.
, vol.11
, Issue.9
, pp. 515-523
-
-
McGlasson, S.1
Jury, A.2
Jackson, A.3
Hunt, D.4
-
5
-
-
0036311308
-
Alpha-interferon-associated thrombotic microangiopathy: A clinicopathologic study of 8 patients and review of the literature
-
Zuber J, Martinez F, Droz D, Oksenhendler E, Legendre C; Groupe D'stude Des Nephrologues D'ile-de-France (GENIF). Alpha-interferon-associated thrombotic microangiopathy: a clinicopathologic study of 8 patients and review of the literature. Medicine (Baltimore). 2002;81(4):321-331.
-
(2002)
Medicine (Baltimore)
, vol.81
, Issue.4
, pp. 321-331
-
-
Zuber, J.1
Martinez, F.2
Droz, D.3
Oksenhendler, E.4
Legendre, C.5
-
6
-
-
84896996710
-
Thrombotic microangiopathy associated with interferon beta
-
Hunt D, Kavanagh D, Drummond I, et al. Thrombotic microangiopathy associated with interferon beta. N Engl J Med. 2014;370(13):1270-1271.
-
(2014)
N Engl J Med.
, vol.370
, Issue.13
, pp. 1270-1271
-
-
Hunt, D.1
Kavanagh, D.2
Drummond, I.3
-
7
-
-
84911421679
-
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β
-
Larochelle C, Grand'maison F, Bernier GP, Latour M, Cailhier JF, Prat A. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β. Mult Scler. 2014;20(13):1783-1787.
-
(2014)
Mult Scler
, vol.20
, Issue.13
, pp. 1783-1787
-
-
Larochelle, C.1
Grand'maison, F.2
Bernier, G.P.3
Latour, M.4
Cailhier, J.F.5
Prat, A.6
-
8
-
-
84930088944
-
Cumulative review of thrombotic microangiopathy, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome reports with subcutaneous interferon β-1a
-
Ben-Amor AF, Trochanov A, Fischer TZ. Cumulative review of thrombotic microangiopathy, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome reports with subcutaneous interferon β-1a. Adv Ther. 2015;32(5):445-454.
-
(2015)
Adv Ther.
, vol.32
, Issue.5
, pp. 445-454
-
-
Ben-Amor, A.F.1
Trochanov, A.2
Fischer, T.Z.3
-
9
-
-
0036307464
-
Causal association in pharmacovigilance and pharmacoepidemiology: Thoughts on the application of the Austin Bradford-Hill criteria
-
Shakir SA, Layton D. Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria. Drug Saf. 2002;25(6):467-471.
-
(2002)
Drug Saf
, vol.25
, Issue.6
, pp. 467-471
-
-
Shakir, S.A.1
Layton, D.2
-
10
-
-
31844443695
-
The environment and disease: Association or causation?
-
Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295-300.
-
(1965)
Proc R Soc Med.
, vol.58
, Issue.5
, pp. 295-300
-
-
Hill, A.B.1
-
11
-
-
10444255401
-
Intravenous immunoglobulin and the kidney - A two-edged sword
-
Orbach H, Tishler M, Shoenfeld Y. Intravenous immunoglobulin and the kidney - a two-edged sword. Semin Arthritis Rheum. 2004;34(3):593-601.
-
(2004)
Semin Arthritis Rheum.
, vol.34
, Issue.3
, pp. 593-601
-
-
Orbach, H.1
Tishler, M.2
Shoenfeld, Y.3
-
12
-
-
0037075272
-
Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin
-
Casadevall N, Nataf J, Viron B, et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med. 2002;346(7):469-475.
-
(2002)
N Engl J Med.
, vol.346
, Issue.7
, pp. 469-475
-
-
Casadevall, N.1
Nataf, J.2
Viron, B.3
-
13
-
-
84964480157
-
A national specialized service in England for atypical haemolytic uraemic syndrome - The first year's experience
-
Sheerin NS, Kavanagh D, Goodship TH, Johnson S. A national specialized service in England for atypical haemolytic uraemic syndrome - the first year's experience. QJM. 2016;109(1):27-33.
-
(2016)
QJM
, vol.109
, Issue.1
, pp. 27-33
-
-
Sheerin, N.S.1
Kavanagh, D.2
Goodship, T.H.3
Johnson, S.4
-
14
-
-
84876575052
-
INTERFEROME v2.0: An updated database of annotated interferon-regulated genes
-
Rusinova I, Forster S, Yu S, et al. INTERFEROME v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 2013;41(D1):D1040-D1046.
-
(2013)
Nucleic Acids Res.
, vol.41
, Issue.D1
, pp. D1040-D1046
-
-
Rusinova, I.1
Forster, S.2
Yu, S.3
-
15
-
-
33846255059
-
Identification of genes selectively regulated by IFNs in endothelial cells
-
Indraccolo S, Pfeffer U, Minuzzo S, et al. Identification of genes selectively regulated by IFNs in endothelial cells. J Immunol. 2007;178(2):1122-1135.
-
(2007)
J Immunol.
, vol.178
, Issue.2
, pp. 1122-1135
-
-
Indraccolo, S.1
Pfeffer, U.2
Minuzzo, S.3
-
16
-
-
0032211097
-
Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration
-
Akwa Y, Hassett DE, Eloranta ML, et al. Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J Immunol. 1998;161(9):5016-5026.
-
(1998)
J Immunol.
, vol.161
, Issue.9
, pp. 5016-5026
-
-
Akwa, Y.1
Hassett, D.E.2
Eloranta, M.L.3
-
17
-
-
0028070714
-
Functional role of type I and type II interferons in antiviral defense
-
Müller U, Steinhoff U, Reis LF, et al. Functional role of type I and type II interferons in antiviral defense. Science. 1994;264(5167):1918-1921.
-
(1994)
Science
, vol.264
, Issue.5167
, pp. 1918-1921
-
-
Müller, U.1
Steinhoff, U.2
Reis, L.F.3
-
18
-
-
84893676729
-
Transsignaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain
-
Campbell IL, Erta M, Lim SL, et al. Transsignaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. J Neurosci. 2014;34(7):2503-2513.
-
(2014)
J Neurosci
, vol.34
, Issue.7
, pp. 2503-2513
-
-
Campbell, I.L.1
Erta, M.2
Lim, S.L.3
-
19
-
-
75749098510
-
The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9
-
Hofer MJ, Li W, Lim SL, Campbell IL. The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9. J Neurosci. 2010;30(3):1149-1157.
-
(2010)
J Neurosci
, vol.30
, Issue.3
, pp. 1149-1157
-
-
Hofer, M.J.1
Li, W.2
Lim, S.L.3
Campbell, I.L.4
-
20
-
-
42149161677
-
Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease
-
Meyer EP, Ulmann-Schuler A, Staufenbiel M, Krucker T. Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease. Proc Natl Acad Sci USA. 2008;105(9):3587-3592.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, Issue.9
, pp. 3587-3592
-
-
Meyer, E.P.1
Ulmann-Schuler, A.2
Staufenbiel, M.3
Krucker, T.4
-
21
-
-
33747159590
-
Genetics of HUS: The impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
-
International Registry of Recurrent and Familial HUS/TTP
-
Caprioli J, Noris M, Brioschi S, et al; International Registry of Recurrent and Familial HUS/TTP. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood. 2006;108(4):1267-1279.
-
(2006)
Blood
, vol.108
, Issue.4
, pp. 1267-1279
-
-
Caprioli, J.1
Noris, M.2
Brioschi, S.3
-
22
-
-
84902589905
-
Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP
-
Cataland SR, Holers VM, Geyer S, Yang S, Wu HM. Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP. Blood. 2014;123(24):3733-3738.
-
(2014)
Blood
, vol.123
, Issue.24
, pp. 3733-3738
-
-
Cataland, S.R.1
Holers, V.M.2
Geyer, S.3
Yang, S.4
Wu, H.M.5
-
23
-
-
84927526565
-
Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome
-
Schramm EC, Roumenina LT, Rybkine T, et al. Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome. Blood. 2015;125(15):2359-2369.
-
(2015)
Blood
, vol.125
, Issue.15
, pp. 2359-2369
-
-
Schramm, E.C.1
Roumenina, L.T.2
Rybkine, T.3
-
24
-
-
40849130173
-
VEGF inhibition and renal thrombotic microangiopathy
-
Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358(11):1129-1136.
-
(2008)
N Engl J Med.
, vol.358
, Issue.11
, pp. 1129-1136
-
-
Eremina, V.1
Jefferson, J.A.2
Kowalewska, J.3
-
25
-
-
38349172121
-
Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome
-
Fang CJ, Fremeaux-Bacchi V, Liszewski MK, et al. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood. 2008;111(2):624-632.
-
(2008)
Blood
, vol.111
, Issue.2
, pp. 624-632
-
-
Fang, C.J.1
Fremeaux-Bacchi, V.2
Liszewski, M.K.3
-
26
-
-
78650106911
-
Anthropometric Reference Data for Children and Adults: United States, 2003-2006
-
Hyattsville, MD: National Center for Health Statistics
-
McDowell MA, Fryar CD, Ogden CL, Flegal KM. Anthropometric Reference Data for Children and Adults: United States, 2003-2006. Hyattsville, MD: National Center for Health Statistics, 2008. National Health Statistics Reports, no. 10.
-
(2008)
National Health Statistics Reports
-
-
McDowell, M.A.1
Fryar, C.D.2
Ogden, C.L.3
Flegal, K.M.4
-
27
-
-
84933279572
-
Aicardi-Goutières syndrome and the type I interferonopathies
-
Crow YJ, Manel N. Aicardi-Goutières syndrome and the type I interferonopathies. Nat Rev Immunol. 2015;15(7):429-440.
-
(2015)
Nat Rev Immunol.
, vol.15
, Issue.7
, pp. 429-440
-
-
Crow, Y.J.1
Manel, N.2
-
28
-
-
84887607415
-
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: A case-control study
-
Rice GI, Forte GM, Szynkiewicz M, et al. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol. 2013;12(12):1159-1169.
-
(2013)
Lancet Neurol.
, vol.12
, Issue.12
, pp. 1159-1169
-
-
Rice, G.I.1
Forte, G.M.2
Szynkiewicz, M.3
-
29
-
-
0344492212
-
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
-
Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA. 2003;100(5):2610-2615.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, Issue.5
, pp. 2610-2615
-
-
Baechler, E.C.1
Batliwalla, F.M.2
Karypis, G.3
-
30
-
-
2442517486
-
Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome
-
Miller DP, Kaye JA, Shea K, et al. Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Epidemiology. 2004;15(2):208-215.
-
(2004)
Epidemiology
, vol.15
, Issue.2
, pp. 208-215
-
-
Miller, D.P.1
Kaye, J.A.2
Shea, K.3
-
31
-
-
85014957424
-
-
Accessed August 2016
-
Toxicologist's review, BLA#99-1488, recombinant human interferon-α2b. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm094485.pdf. Accessed August 2016.
-
Toxicologist's Review, BLA#99-1488, Recombinant Human Interferon-α2b
-
-
-
32
-
-
85014878986
-
-
Accessed August 2016
-
Toxicologist's review, PLA#98-0261, recombinant human interferon-β1a. http://www.fda.gov/downloads/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/therapeuticbiologicapplications/ucm106138.pdf. Accessed August 2016.
-
Toxicologist's Review, PLA#98-0261, Recombinant Human Interferon-β1a
-
-
-
33
-
-
0345601517
-
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
-
Ebers GC; PRISMS (Prevention of Relapses and Disability by Interferon β-1a Subcutaneously in Multiple Sclerosis) Study Group. Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis. Lancet. 1998;352(9139):1498-1504.
-
(1998)
Lancet
, vol.352
, Issue.9139
, pp. 1498-1504
-
-
Ebers, G.C.1
-
34
-
-
22744434433
-
Causation and causal inference in epidemiology
-
Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005;95(suppl 1):S144-S150.
-
(2005)
Am J Public Health
, vol.95
, pp. S144-S150
-
-
Rothman, K.J.1
Greenland, S.2
-
35
-
-
84896546294
-
Thrombotic microangiopathy in interferon beta treated multiple sclerosis patients: Review of literature and report of two new cases
-
Vosoughi R, Marriott JJ. Thrombotic microangiopathy in interferon beta treated multiple sclerosis patients: review of literature and report of two new cases. Mult Scler Relat Disord. 2014;3(3):321-325.
-
(2014)
Mult Scler Relat Disord
, vol.3
, Issue.3
, pp. 321-325
-
-
Vosoughi, R.1
Marriott, J.J.2
-
36
-
-
84898544834
-
Malignant hypertension and interferon-beta: A case report
-
Rubin S, Lacraz A, Galantine V, Gosse P. Malignant hypertension and interferon-beta: a case report. J Hum Hypertens. 2014;28(5):340-341.
-
(2014)
J Hum Hypertens
, vol.28
, Issue.5
, pp. 340-341
-
-
Rubin, S.1
Lacraz, A.2
Galantine, V.3
Gosse, P.4
-
37
-
-
0037451167
-
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
-
Bennett L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003;197(6):711-723.
-
(2003)
J Exp Med.
, vol.197
, Issue.6
, pp. 711-723
-
-
Bennett, L.1
Palucka, A.K.2
Arce, E.3
-
38
-
-
57649133143
-
Cutaneous histopathological findings of Aicardi-Goutières syndrome, overlap with chilblain lupus
-
Kolivras A, Aeby A, Crow YJ, Rice GI, Sass U, André J. Cutaneous histopathological findings of Aicardi-Goutières syndrome, overlap with chilblain lupus. J Cutan Pathol. 2008;35(8):774-778.
-
(2008)
J Cutan Pathol.
, vol.35
, Issue.8
, pp. 774-778
-
-
Kolivras, A.1
Aeby, A.2
Crow, Y.J.3
Rice, G.I.4
Sass, U.5
André, J.6
-
39
-
-
18444387671
-
Cerebral thrombotic microangiopathy and antiphospholipid antibodies in Aicardi-Goutieres syndrome - report of two sisters
-
Rasmussen M, Skullerud K, Bakke SJ, Lebon P, Jahnsen FL. Cerebral thrombotic microangiopathy and antiphospholipid antibodies in Aicardi-Goutieres syndrome - report of two sisters. Neuropediatrics. 2005;36(1):40-44.
-
(2005)
Neuropediatrics
, vol.36
, Issue.1
, pp. 40-44
-
-
Rasmussen, M.1
Skullerud, K.2
Bakke, S.J.3
Lebon, P.4
Jahnsen, F.L.5
-
40
-
-
84872140900
-
The spectrum of renal thrombotic microangiopathy in lupus nephritis
-
Song D, Wu LH, Wang FM, et al. The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther. 2013;15:R12.
-
(2013)
Arthritis Res Ther.
, vol.15
, pp. R12
-
-
Song, D.1
Wu, L.H.2
Wang, F.M.3
-
41
-
-
0036281509
-
The neuropathology and pathogenesis of systemic lupus erythematosus
-
Scolding NJ, Joseph FG. The neuropathology and pathogenesis of systemic lupus erythematosus. Neuropathol Appl Neurobiol. 2002;28(3):173-189.
-
(2002)
Neuropathol Appl Neurobiol
, vol.28
, Issue.3
, pp. 173-189
-
-
Scolding, N.J.1
Joseph, F.G.2
|